Markets:

Overview

News

Currencies

International

Treasuries

Myovant Sciences Ltd. Common Shares (NY:MYOV)

N/A UNCHANGED

Last Price Updated: 7:00 PM EST, Mar 9, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Myovant Sciences Ltd. Common Shares

< Previous 1 2 3 4 5 Next >

Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08

October 18, 2022

From Myovant Sciences, Inc.

Via GlobeNewswire

CORRECTION -- Myovant Sciences, Inc.

October 14, 2022

From Myovant Sciences, Inc.

Via GlobeNewswire

Myovant Sciences to Host Second Fiscal Quarter 2022 Earnings Conference Call at 5:00 p.m.

October 14, 2022

From Myovant Sciences, Inc.

Via GlobeNewswire

Why Is Myovant Sciences (MYOV) Stock Up 30% Today? ↗

October 03, 2022

The prospect that shareholders could get 27% or more to tender their shares has MYOV stock up sharply today.

Via InvestorPlace

Myovant Sciences Rejects Sumitovant/Sumitomo Pharma Buyout Offer Of $2.5B ↗

October 03, 2022

Via Benzinga

October 04, 2022

Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) shares surged 637.6% to close at $2.01 on Monday after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per...

Via Benzinga

Nasdaq Jumps 270 Points; Silver Surges Over 8% ↗

October 03, 2022

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite climbing around 270 points on Monday.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

October 03, 2022

Gainers

Via Benzinga

Why Tesla Shares Are Trading Lower By Over 7%, Here Are 52 Stocks Moving In Monday's Mid-Day Session ↗

October 03, 2022

Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) gained 641% to $2.0207 after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per share.

Via Benzinga

S&P 500 Surges 2%; Crude Oil Rises Sharply ↗

October 03, 2022

U.S. stocks extended gains midway through trading, with the Dow Jones gaining more than 600 points on Monday.

Via Benzinga

Blue Apron (APRN) Stock Falls 33% on CFO Departure, Stock Sale ↗

October 03, 2022

Blue Apron (APRN) stock is sliding lower on Monday as investors react to its CFO leaving the company and plans for a stock sale.

Via InvestorPlace

Myovant Sciences Rockets After Rejecting Lowball Sumitovant Biopharma Takeover Bid ↗

October 03, 2022

Myovant shares rocketed to a year-high after turning down Sumitovant's offer.

Via Investor's Business Daily

US Stocks Open Higher; Dow Jumps 250 Points ↗

October 03, 2022

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 250 points on Monday.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 03, 2022

Gainers LogicBio Therapeutics (NASDAQ:LOGC) shares moved upwards by 641.3% to $2.02 during Monday's pre-market session. The company's market cap stands at $66.5 million.

Via Benzinga

Why Myovant Sciences Shares Are Skyrocketing Monday ↗

October 03, 2022

Myovant Sciences Ltd (NYSE: MYOV) shares are trading higher by 30.85% to $23.50 during Monday's pre-market session after the company received an acquisition offer from Sumitovant Biopharma and...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

October 03, 2022

We're starting off the week with a breakdown of the biggest pre-market stock movers traders need to know about for Monday morning!

Via InvestorPlace

Why Myovant Sciences Is Trading Higher By Over 26%; Here Are 31 Stocks Moving Premarket ↗

October 03, 2022

Gainers Wearable Devices Ltd. (NASDAQ: WLDS) rose 58% to $1.39 in pre-market trading after declining around 8% on Friday. Wearable Devices, last week, posted a 1H loss of $0.18 per share.

Via Benzinga

Myovant Sciences Special Committee of Board Confirms Receipt of Preliminary, Non-binding Proposal from Sumitovant Biopharma and Sumitomo Pharma to Acquire Remaining Shares

October 02, 2022

From Myovant Sciences, Inc.

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2022 ↗

August 09, 2022

Via Benzinga

Karuna Therapeutics To $276? Plus SVB Leerink Almost Doubles Price Target On This Stock ↗

August 09, 2022

Mizuho boosted the price target for Karuna Therapeutics, Inc. (NASDAQ: KRTX) from $190 to $276. Karuna Therapeutics shares fell 1.3% to $238.00 in pre-market trading.

Via Benzinga

FDA Approves Myovant Sciences/Pfizer's Treatment For Endometriosis-Associated Pain ↗

August 08, 2022

Via Benzinga

Biotech Daily: Thumbs Down For Acadia's Antipsychotic Drug, Akebia Fails COVID-19 Study, Kazia's Encouraging Data In Brain Metastases ↗

August 05, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Myovant Sciences's Return On Invested Capital Insights ↗

August 01, 2022

According to data from Benzinga Pro, during Q1, Myovant Sciences's (NYSE:MYOV) reported sales totaled $116.49 million. Despite a 64.17% increase in earnings, the company posted a loss of $21.24...

Via Benzinga

Biotech Investors: August's Key PDUFA Catalysts You Must Know ↗

July 31, 2022

Regulatory decisions have yet to pick up pace this year. July’s calendar was light, but the good news was that most decisions turned out to be positive. That said, none of the drugs approved during the...

Via Benzinga

Recap: Myovant Sciences Q1 Earnings ↗

July 27, 2022

Myovant Sciences (NYSE:MYOV) reported its Q1 earnings results on Wednesday, July 27, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Myovant Sciences beat...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

July 27, 2022

Gainers

Via Benzinga

Myovant Sciences Announces Corporate Updates and Financial Results for First Fiscal Quarter 2022

July 27, 2022

From Myovant Sciences, Inc.

Via GlobeNewswire

Daily Biotech Pulse: Teva's Opioids Settlement, Criminal Investigation Against Cassava, Durable Responses For IN8bio's Leukemia Therapy ↗

July 27, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Earnings Scheduled For July 27, 2022 ↗

July 27, 2022

Companies Reporting Before The Bell • Equinor (NYSE:EQNR) is projected to report earnings for its second quarter.

Via Benzinga

Earnings Outlook For Myovant Sciences ↗

July 26, 2022

Myovant Sciences (NYSE:MYOV) is set to give its latest quarterly earnings report on Wednesday, 2022-07-27. Here's what investors need to know before the announcement. Analysts estimate that Myovant...

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Myovant Sciences Ltd. Common Shares (NY:MYOV)

All News about Myovant Sciences Ltd. Common Shares

Starting at $3.75/week.

Subscribe Today